Midnight is a modern hybrid-indica variety whose exact origins remain undocumented. Breeders have not provided a definitive account of its lineage, though Oooze is officially recognized as a parent. Given the lack of extensive historical data, there is no public record of a specific breeder or the circumstances under which this strain was developed. Consequently, its development history remains incomplete and the full scope of its genetic heritage continues to be a subject of uncertainty.

The aromatic and sensory profile of Midnight is characterized by a complex, diverse array of terpenes that begins with limonene, caryophyllene, and linalool. These are supported by a confirmed presence of pinene, beta-pinene, humulene, bisabolol, myrcene, nerolidol, valencene, caryophyllene-oxide, ocimene, camphene, gamma-terpinene, borneol, eucalyptol, and terpinolene. Because the cannabinoid content is based on averaged figures, the strain contains an estimated 8.3% THC, 0.05% CBD, and 0.2% CBG. This chemical configuration suggests a nuanced sensory experience driven by this specific, verified sequence of secondary metabolites.

Midnight produces effects described as relaxed and focused, making it a functional option for users seeking relief from pain, stress, or sleep difficulties. It is a moderately difficult strain to cultivate that performs well in both indoor and outdoor environments, offering a high yield after a 60-day flowering period. There are currently no recorded offspring for this variety, marking its genetic legacy as localized and singular within its generation.